Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

A patient's grey hair regained color during treatment with adalimumab.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Cepharanthine could be a strong antiviral against COVID-19.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

A new compound was effective for imaging prostate cancer in rats.

CD206+ macrophages are crucial for hair growth in alopecia areata treatment.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

RCS-01 is safe and may help rejuvenate aging skin.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Most adverse reactions to the treatment were mild, with nausea being the most common.